Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 19122519)

1.

A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes.

Davis-Richardson AG, Triplett EW.

Diabetologia. 2015 Jul;58(7):1386-93. doi: 10.1007/s00125-015-3614-8. Epub 2015 May 10.

2.

Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes.

Purohit S, Sharma A, She JX.

Biomed Res Int. 2015;2015:326918. doi: 10.1155/2015/326918. Epub 2015 Mar 25. Review.

3.

Type 1 diabetes and gut microbiota: Friend or foe?

Hu C, Wong FS, Wen L.

Pharmacol Res. 2015 Aug;98:9-15. doi: 10.1016/j.phrs.2015.02.006. Epub 2015 Mar 5. Review.

PMID:
25747961
4.
5.

Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.

Precechtelova J, Borsanyiova M, Sarmirova S, Bopegamage S.

J Pathog. 2014;2014:738512. doi: 10.1155/2014/738512. Epub 2014 Dec 10. Review.

6.

Gut microbiota and type 1 diabetes.

Vaarala O.

Rev Diabet Stud. 2012 Winter;9(4):251-9. doi: 10.1900/RDS.2012.9.251. Epub 2012 Dec 28. Review.

7.

Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Arvonen M, Vähäsalo P, Turunen S, Salo HM, Mäki M, Laurila K, Vaarala O, Karttunen TJ.

Clin Exp Immunol. 2012 Dec;170(3):266-73. doi: 10.1111/j.1365-2249.2012.04663.x.

8.

Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes.

Lahdenperä AI, Hölttä V, Ruohtula T, Salo HM, Orivuori L, Westerholm-Ormio M, Savilahti E, Fälth-Magnusson K, Högberg L, Ludvigsson J, Vaarala O.

Clin Exp Immunol. 2012 Feb;167(2):226-34. doi: 10.1111/j.1365-2249.2011.04510.x.

9.

Enterocytes' tight junctions: From molecules to diseases.

Assimakopoulos SF, Papageorgiou I, Charonis A.

World J Gastrointest Pathophysiol. 2011 Dec 15;2(6):123-37. doi: 10.4291/wjgp.v2.i6.123.

10.

BB rat Gimap gene expression in sorted lymphoid T and B cells.

Moralejo DH, Fuller JM, Rutledge EA, Van Yserloo B, Ettinger RA, Jensen R, Osborne W, Kwitek A, Lernmark A.

Life Sci. 2011 Nov 7;89(19-20):748-54. doi: 10.1016/j.lfs.2011.08.016. Epub 2011 Sep 10.

11.

Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice.

Galipeau HJ, Rulli NE, Jury J, Huang X, Araya R, Murray JA, David CS, Chirdo FG, McCoy KD, Verdu EF.

J Immunol. 2011 Oct 15;187(8):4338-46. doi: 10.4049/jimmunol.1100854. Epub 2011 Sep 12.

12.

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Tlaskalová-Hogenová H, Stěpánková R, Kozáková H, Hudcovic T, Vannucci L, Tučková L, Rossmann P, Hrnčíř T, Kverka M, Zákostelská Z, Klimešová K, Přibylová J, Bártová J, Sanchez D, Fundová P, Borovská D, Srůtková D, Zídek Z, Schwarzer M, Drastich P, Funda DP.

Cell Mol Immunol. 2011 Mar;8(2):110-20. doi: 10.1038/cmi.2010.67. Epub 2011 Jan 31. Review.

13.

Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Rapin JR, Wiernsperger N.

Clinics (Sao Paulo). 2010 Jun;65(6):635-43. doi: 10.1590/S1807-59322010000600012. Review.

14.

Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change.

Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hänninen A.

Diabetes. 2010 Sep;59(9):2237-46. doi: 10.2337/db10-0147. Epub 2010 Jun 14.

15.

Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development.

Wang HJ, Zakhari S, Jung MK.

World J Gastroenterol. 2010 Mar 21;16(11):1304-13. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk